Skye Bioscience, Inc.

SKYE · Nasdaq · SIC 2834: Pharmaceutical Preparations
198
SEC Filings

Business Summary

. Overview Skye Bioscience, Inc. is a clinical-stage biotechnology company pioneering next-generation molecules that modulate G-protein-coupled receptors ("GPCRs") to treat obesity, overweight, and metabolic disorders. Our lead candidate, nimacimab, is a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 ("CB1")a key GPCR involved in metabolic regulation. Except where the context indicates otherwise, references to "we," "us," "our," "Skye" or the" Co...

Next Earnings

Q2 FY2026 — expected 2026-08-04

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSKYEdiscussed_in_filing Cybersecurity
topic_mentionSKYEdiscussed_in_filing Trusted Computing
topic_mentionSKYEdiscussed_in_filing Blockchain & Crypto
topic_mentionSKYEdiscussed_in_filing Supply Chain
topic_mentionSKYEdiscussed_in_filing Regulation
topic_mentionSKYEdiscussed_in_filing Automotive
topic_mentionSKYEdiscussed_in_filing Healthcare & Bio
topic_mentionSKYEdiscussed_in_filing Sovereign & Government
topic_mentionSKYEdiscussed_in_filing Cybersecurity
topic_mentionSKYEdiscussed_in_filing Trusted Computing
topic_mentionSKYEdiscussed_in_filing Blockchain & Crypto
topic_mentionSKYEdiscussed_in_filing Supply Chain
topic_mentionSKYEdiscussed_in_filing Regulation
topic_mentionSKYEdiscussed_in_filing Automotive
topic_mentionSKYEdiscussed_in_filing Healthcare & Bio
topic_mentionSKYEdiscussed_in_filing Sovereign & Government
topic_mentionSKYEdiscussed_in_filing Cybersecurity
topic_mentionSKYEdiscussed_in_filing Trusted Computing
topic_mentionSKYEdiscussed_in_filing Blockchain & Crypto
topic_mentionSKYEdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001628280-26-016394EDGAR79K words
2025-03-202024-12-310001516551-25-000027EDGAR—
2024-03-222023-12-310001516551-24-000048EDGAR—
2023-03-312022-12-310001516551-23-000038EDGAR—
2022-03-282021-12-310001516551-22-000004EDGAR—
2021-03-022020-12-310001640334-21-000483EDGAR—
2020-03-232019-12-310001640334-20-000582EDGAR—
2019-03-142018-12-310001640334-19-000379EDGAR—
2018-03-192017-12-310001640334-18-000482EDGAR—
2017-03-102016-12-310001640334-17-000456EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001628280-25-051031EDGAR13K words
2025-08-072025-06-300001516551-25-000049EDGAR—
2025-05-082025-03-310001516551-25-000042EDGAR—
2024-11-072024-09-300001516551-24-000110EDGAR—
2024-08-092024-06-300001516551-24-000070EDGAR—
2024-05-102024-03-310001516551-24-000055EDGAR—
2023-11-142023-09-300001516551-23-000100EDGAR—
2023-08-072023-06-300001516551-23-000044EDGAR—
2023-05-122023-03-310001516551-23-000041EDGAR—
2022-11-142022-09-300001516551-22-000040EDGAR—
2022-08-152022-06-300001516551-22-000022EDGAR—
2022-05-062022-03-310001516551-22-000006EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001628280-26-023699EDGAR5K words
2026-03-190001628280-26-019878EDGAR—
2026-03-100001628280-26-016400EDGAR—
2026-02-200001628280-26-010186EDGAR—
2026-02-020001628280-26-004451EDGAR—
2025-12-230001628280-25-058729EDGAR—
2025-11-100001628280-25-051035EDGAR—
2025-10-060001628280-25-044223EDGAR—
2025-08-070001516551-25-000050EDGAR—
2025-06-110001516551-25-000046EDGAR—

198 total filings indexed. 166 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001516551
TickerSKYE
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 92095f2df8c6cc8f1729cae169e1f5e3526f83564ba4863c5fd813cf4dcf4ddf
parent: c31f097dcbfe5d44a8168c0c72fd6e53c6630fc0b6b16c0dcf4e2fa37e949ba4
content hash: 9561efbd5d1957f17752f1f0828e755e15634f89e03d9f286bcb73f66de255ee
signed: 2026-04-13T04:47:28.026Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf